| Literature DB >> 29101116 |
Siddharth Patel1, Lucia Kwak1, Sunil K Agarwal2, Larisa G Tereshchenko3, Josef Coresh1, Elsayed Z Soliman4, Kunihiro Matsushita5.
Abstract
BACKGROUND: A few studies have recently reported clockwise and counterclockwise rotations of QRS transition zone as predictors of mortality. However, their prospective correlates and associations with individual cardiovascular disease (CVD) outcomes are yet to be investigated. METHODS ANDEntities:
Keywords: QRS transition zone; cardiovascular outcomes; electrocardiography; epidemiology; mortality
Mesh:
Year: 2017 PMID: 29101116 PMCID: PMC5721743 DOI: 10.1161/JAHA.117.006281
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 5.501
Figure 1Scheme for no rotation, counterclockwise rotation, and clockwise rotation of QRS transition zone.
Baseline Characteristics According to QRS Transition Zone Rotation
| ECG Rotation Status |
| ||||
|---|---|---|---|---|---|
| Counterclockwise | No Rotation | Clockwise | |||
| No. (%) | 7171 | 5500 | 896 | ||
| Age, (SD), y | 54.5 (5.8) | 54.3 (5.7) | 53.9 (5.7) | 0.006 | |
| Race, No. (%) | |||||
| Black | 1939 (27) | 1390 (25) | 227 (25) | 0.067 | |
| White | 5232 (73) | 4110 (75) | 669 (75) | ||
| Sex, No. (%) | |||||
| Female | 4290 (60) | 2854 (52) | 511 (57) | <0.001 | |
| Male | 2881 (40) | 2646 (48) | 385 (43) | ||
| Education, No. (%) | |||||
| Basic | 1576 (22) | 1203 (22) | 234 (26) | 0.012 | |
| Intermediate | 2943 (41) | 2252 (41) | 377 (42) | ||
| High | 2638 (37) | 2037 (37) | 285 (32) | ||
| BMI, kg/m2 | 27.8 (5.2) | 27.2 (5.2) | 27.1 (6.2) | <0.001 | |
| Current smoker, No. (%) | 1576 (22) | 1591 (29) | 317 (35) | <0.001 | |
| Current drinker, No. (%) | 4031 (56) | 3189 (58) | 499 (56) | 0.103 | |
| Diabetes mellitus, No. (%) | 659 (9) | 625 (11) | 120 (13) | <0.001 | |
| Hypertension, No. (%) | 2209 (31) | 1748 (32) | 315 (35) | 0.023 | |
| Total cholesterol, mmol/L | 5.56 (1.08) | 5.52 (1.08) | 5.52 (1.06) | 0.121 | |
| HDL cholesterol, mmol/L | 1.36 (0.43) | 1.34 (0.45) | 1.37 (0.45) | 0.086 | |
Values are expressed as mean (SD) or number (percentage). Baseline characteristics were compared across counterclockwise, no, and clockwise rotation of QRS transition zone. BMI indicates body mass index; HDL, high‐density lipoprotein.
Baseline ECG Characteristics According to QRS Transition Zone Rotation
| Counterclockwise, % | No Rotation, % | Clockwise, % |
| |
|---|---|---|---|---|
| Major ECG abnormality | 6.2 | 7.7 | 10.7 | <0.001 |
| Major Q wave abnormalities (old MI) | 1.4 | 1.8 | 2.8 | 0.009 |
| Minor Q, QS waves with ST, T abnormalities (possible old MI) | 0.28 | 0.58 | 0.45 | 0.031 |
| Major isolated ST/T abnormalities | 4.0 | 5.3 | 7.3 | <0.001 |
| Left ventricular hypertrophy+major STT change | 1.1 | 1.3 | 1.5 | 0.646 |
| Atrial fibrillation | 0.08 | 0.15 | 0.22 | 0.385 |
| Mobiz type II, second‐degree atrioventricular block, Wenckebach phenomenon | 0 | 0.02 | 0 | 0.480 |
| Major QT prolongation ≥116% | 1.1 | 1.1 | 1.6 | 0.402 |
| Atrial flutter, intermittent atrial fibrillation, intermittent atrial flutter | 0 | 0.04 | 0 | 0.231 |
| Minor ECG abnormality | 41.4 | 51.8 | 61.1 | <0.001 |
| Minor isolated Q, QS waves | 4.3 | 6.8 | 9.6 | <0.001 |
| Minor isolated ST, T abnormalities | 10.1 | 11.2 | 14.5 | <0.001 |
| High R waves | 9.8 | 8.2 | 4.1 | <0.001 |
| ST‐segment elevation, anterolateral site | 0.25 | 0.18 | 0 | 0.258 |
| ST‐segment elevation, posterior site | 0.25 | 0.22 | 0 | 0.320 |
| ST‐segment elevation, anterior site | 1.6 | 1.5 | 1.0 | 0.323 |
| Incomplete RBBB | 11.3 | 20.2 | 25.6 | <0.001 |
| Incomplete LBBB | 1.9 | 2.7 | 3.9 | <0.001 |
| Minor QT prolongation ≥112% | 3.3 | 3.4 | 4.0 | 0.538 |
| Short PR interval | 1.5 | 1.6 | 2.0 | 0.455 |
| Left axis deviation | 2.2 | 4.3 | 9.8 | <0.001 |
| Right axis deviation | 0 | 0.05 | 0.11 | 0.069 |
| Frequent ventricular premature beats | 1.3 | 1.6 | 1.3 | 0.245 |
| PR interval >0.22 s | 1.9 | 2.4 | 2.5 | 0.170 |
| Frequent atrial or premature beats | 1.4 | 1.8 | 1.5 | 0.554 |
| Supraventricular rhythm | 0.11 | 0.25 | 0.22 | 0.156 |
| Sinus tachycardia | 0.32 | 0.45 | 0.56 | 0.346 |
| Sinus bradycardia | 3.3 | 3.9 | 4.6 | 0.057 |
| Low QRS amplitude | 0.79 | 1.49 | 4.13 | <0.001 |
| P‐wave amplitude high | 1.3 | 1.6 | 3.0 | <0.001 |
LBBB indicates left bundle branch block; MI, myocardial infarction; RBBB, right bundle branch block.
Pattern of Changes in QRS Transition Zone Rotation Among Participants Who Had ECGs Recorded at all Visits From Visit 1 Through Visit 4
| ECG Rotation Status at Visit 1 | Followed ECG Rotation Status From Visit 2 to Visit 4 | No. (%) |
|---|---|---|
| No rotation (n=3605) | Only no rotation | 1516 (42.1) |
| Experienced both counterclockwise and clockwise | 22 (0.6) | |
| Experienced counterclockwise | 1666 (46.2) | |
| Experienced clockwise | 401 (11.1) | |
| Counterclockwise (n=4936) | Only counterclockwise | 3581 (72.5) |
| Experienced clockwise (some experienced no rotation as well) | 37 (0.8) | |
| Experienced no rotation but not clockwise | 1318 (26.7) | |
| Clockwise (n=527) | Only clockwise | 175 (33.2) |
| Experienced counterclockwise (some experienced no rotation as well) | 44 (8.4) | |
| Experienced no rotation but not counterclockwise | 308 (58.4) |
RRR of Changes From no Rotation According to Each Predictor Tested
| Counterclockwise | Clockwise | |||
|---|---|---|---|---|
| RRR |
| RRR (95% CI) |
| |
| Age | 1.01 (1.00–1.02) | 0.185 | 1.02 (1.00–1.04) | 0.095 |
| Male | 0.98 (0.84–1.15) | 0.821 | 0.98 (0.77–1.27) | 0.904 |
| Black | 1.34 (1.09–1.65) | 0.005 | 1.07 (0.78–1.48) | 0.672 |
| Education | ||||
| Intermediate | 0.98 (0.79–1.22) | 0.866 | 1.00 (0.71–1.40) | 0.989 |
| High | 0.86 (0.69–1.07) | 0.178 | 1.02 (0.72–1.43) | 0.932 |
| Current smoker | 0.94 (0.79–1.11) | 0.466 | 1.08 (0.83–1.42) | 0.563 |
| Current drinker | 0.98 (0.83–1.15) | 0.775 | 1.00 (0.77–1.29) | 0.985 |
| Hypertension | 1.05 (0.89–1.25) | 0.540 | 1.25 (0.96–1.62) | 0.097 |
| Diabetes mellitus | 0.86 (0.66–1.12) | 0.254 | 1.58 (1.10–2.26) | 0.013 |
| Body mass index | 1.00 (0.99–1.02) | 0.880 | 1.02 (0.99–1.04) | 0.168 |
| Total cholesterol | 1.07 (1.00–1.15) | 0.067 | 0.99 (0.88–1.11) | 0.841 |
| HDL cholesterol | 0.92 (0.76–1.11) | 0.382 | 1.23 (0.93–1.64) | 0.152 |
CI indicates confidence interval; HDL, high‐density lipoprotein.
Relative risk ratio (RRR): the reference group included those who had no rotation across all 4 visits.
Figure 2Incident rate (per 1000 person‐years) of cardiovascular events according to ECG QRS transition rotation. CHD indicates coronary heart disease; HF, heart failure.
Association of Counterclockwise and Clockwise Rotation of QRS Transition Zone With Incident Cardiovascular Outcomes
| Counterclockwise | Clockwise | |||||
|---|---|---|---|---|---|---|
| HR | 95% CI |
| HR | 95% CI |
| |
| CHD | ||||||
| Model 1 | 0.88 | (0.81–0.96) | 0.003 | 1.12 | (0.94–1.33) | 0.192 |
| Model 2 | 0.91 | (0.83–0.99) | 0.024 | 1.10 | (0.93–1.31) | 0.269 |
| Model 3 | 0.95 | (0.87–1.04) | 0.265 | 1.04 | (0.88–1.24) | 0.642 |
| Model 4 | 1.00 | (0.91–1.09) | 0.923 | 0.95 | (0.79–1.13) | 0.543 |
| HF | ||||||
| Model 1 | 0.83 | (0.76–0.91) | <0.001 | 1.53 | (1.30–1.79) | <0.001 |
| Model 2 | 0.79 | (0.72–0.86) | <0.001 | 1.42 | (1.21–1.67) | <0.001 |
| Model 3 | 0.86 | (0.79–0.95) | 0.002 | 1.35 | (1.15–1.59) | <0.001 |
| Model 4 | 0.92 | (0.84–1.01) | 0.077 | 1.20 | (1.02–1.41) | 0.031 |
| Stroke | ||||||
| Model 1 | 0.85 | (0.75–0.98) | 0.020 | 1.32 | (1.03–1.69) | 0.030 |
| Model 2 | 0.82 | (0.71–0.93) | 0.003 | 1.24 | (0.96–1.59) | 0.093 |
| Model 3 | 0.87 | (0.76–1.00) | 0.057 | 1.15 | (0.89–1.48) | 0.298 |
| Model 4 | 0.92 | (0.80–1.06) | 0.232 | 1.05 | (0.81–1.35) | 0.737 |
| CVD | ||||||
| Model 1 | 0.85 | (0.80–0.91) | <0.001 | 1.25 | (1.10–1.41) | 0.001 |
| Model 2 | 0.85 | (0.79–0.90) | <0.001 | 1.20 | (1.06–1.36) | 0.005 |
| Model 3 | 0.89 | (0.83–0.95) | 0.001 | 1.12 | (0.98–1.27) | 0.095 |
| Model 4 | 0.93 | (0.87–1.00) | 0.037 | 1.02 | (0.90–1.16) | 0.749 |
| Death | ||||||
| Model 1 | 0.80 | (0.75–0.86) | <0.001 | 1.49 | (1.33–1.67) | <0.001 |
| Model 2 | 0.78 | (0.73–0.83) | <0.001 | 1.40 | (1.25–1.57) | <0.001 |
| Model 3 | 0.85 | (0.80–0.91) | <0.001 | 1.34 | (1.20–1.51) | <0.001 |
| Model 4 | 0.88 | (0.83–0.94) | <0.001 | 1.25 | (1.12–1.41) | <0.001 |
| CVD mortality | ||||||
| Model 1 | 0.65 | (0.56–0.75) | <0.001 | 1.61 | (1.27–2.03) | <0.001 |
| Model 2 | 0.62 | (0.54–0.72) | <0.001 | 1.46 | (1.16–1.85) | 0.001 |
| Model 3 | 0.70 | (0.60–0.81) | <0.001 | 1.37 | (1.08–1.74) | 0.010 |
| Model 4 | 0.76 | (0.65–0.88) | <0.001 | 1.14 | (0.90–1.45) | 0.284 |
| Non‐CVD mortality | ||||||
| Model 1 | 0.85 | (0.79–0.91) | <0.001 | 1.46 | (1.28–1.66) | <0.001 |
| Model 2 | 0.83 | (0.77–0.89) | <0.001 | 1.38 | (1.22–1.57) | <0.001 |
| Model 3 | 0.90 | (0.84–0.97) | 0.006 | 1.33 | (1.17–1.52) | <0.001 |
| Model 4 | 0.92 | (0.85–0.99) | 0.024 | 1.28 | (1.12–1.46) | <0.001 |
Model 1: crude model. Model 2: adjusted for age, sex, race, and education level. Model 3: further adjusted for current smoking status, current drinking status, hypertension, diabetes mellitus, total and high‐density lipoprotein cholesterol levels, and body mass index. Model 4: additionally adjusted for major and minor ECG abnormalities. CHD indicates coronary heart disease; CI, confidence interval; CVD, cardiovascular disease; HF, heart failure; HR, hazard ratio; OR, odds ratio.